These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25964249)

  • 21. Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men.
    Petrick JL; Hyland PL; Caron P; Falk RT; Pfeiffer RM; Dawsey SM; Abnet CC; Taylor PR; Weinstein SJ; Albanes D; Freedman ND; Gapstur SM; Bradwin G; Guillemette C; Campbell PT; Cook MB
    J Natl Cancer Inst; 2019 Jan; 111(1):34-41. PubMed ID: 29788475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
    Lukanova A; Lundin E; Micheli A; Arslan A; Ferrari P; Rinaldi S; Krogh V; Lenner P; Shore RE; Biessy C; Muti P; Riboli E; Koenig KL; Levitz M; Stattin P; Berrino F; Hallmans G; Kaaks R; Toniolo P; Zeleniuch-Jacquotte A
    Int J Cancer; 2004 Jan; 108(3):425-32. PubMed ID: 14648710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Sex Hormone Levels and Risk of Esophageal Adenocarcinoma in a Prospective Study in Men.
    Xie SH; Ness-Jensen E; Rabbani S; Langseth H; Gislefoss RE; Mattsson F; Lagergren J
    Am J Gastroenterol; 2020 Feb; 115(2):216-223. PubMed ID: 31658123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.
    ; Key TJ; Appleby PN; Reeves GK; Travis RC; Alberg AJ; Barricarte A; Berrino F; Krogh V; Sieri S; Brinton LA; Dorgan JF; Dossus L; Dowsett M; Eliassen AH; Fortner RT; Hankinson SE; Helzlsouer KJ; Hoff man-Bolton J; Comstock GW; Kaaks R; Kahle LL; Muti P; Overvad K; Peeters PH; Riboli E; Rinaldi S; Rollison DE; Stanczyk FZ; Trichopoulos D; Tworoger SS; Vineis P
    Lancet Oncol; 2013 Sep; 14(10):1009-19. PubMed ID: 23890780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.
    Black A; Pinsky PF; Grubb RL; Falk RT; Hsing AW; Chu L; Meyer T; Veenstra TD; Xu X; Yu K; Ziegler RG; Brinton LA; Hoover RN; Cook MB
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2374-82. PubMed ID: 25178985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis.
    Mori N; Keski-Rahkonen P; Gicquiau A; Rinaldi S; Dimou N; Harlid S; Harbs J; Van Guelpen B; Aune D; Cross AJ; Tsilidis KK; Severi G; Kvaskoff M; Fournier A; Kaaks R; Fortner RT; Schulze MB; Jakszyn P; Sánchez MJ; Colorado-Yohar SM; Ardanaz E; Travis R; Watts EL; Masala G; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; Gram IT; Waaseth M; Gunter MJ; Murphy N
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum sex hormone levels are related to breast cancer risk in postmenopausal women.
    Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):583-5. PubMed ID: 9167999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial.
    Kalish GM; Barrett-Connor E; Laughlin GA; Gulanski BI;
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1646-52. PubMed ID: 12679451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
    ; Roddam AW; Allen NE; Appleby P; Key TJ
    J Natl Cancer Inst; 2008 Feb; 100(3):170-83. PubMed ID: 18230794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer.
    Gershman B; Shui IM; Stampfer M; Platz EA; Gann PH; Sesso HL; DuPre N; Giovannucci E; Mucci LA
    Eur Urol; 2014 Apr; 65(4):683-9. PubMed ID: 23340241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.
    Falk RT; Gentzschein E; Stanczyk FZ; Garcia-Closas M; Figueroa JD; Ioffe OB; Lissowska J; Brinton LA; Sherman ME
    Breast Cancer Res Treat; 2012 Jan; 131(1):287-94. PubMed ID: 21870130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
    Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
    Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
    Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
    Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Hsing AW; Crawford ED; Andriole GL; Kaaks R; Hayes RB
    Int J Cancer; 2008 May; 122(10):2345-50. PubMed ID: 18172860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
    Toniolo PG; Levitz M; Zeleniuch-Jacquotte A; Banerjee S; Koenig KL; Shore RE; Strax P; Pasternack BS
    J Natl Cancer Inst; 1995 Feb; 87(3):190-7. PubMed ID: 7707406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.
    Hankinson SE; Willett WC; Manson JE; Colditz GA; Hunter DJ; Spiegelman D; Barbieri RL; Speizer FE
    J Natl Cancer Inst; 1998 Sep; 90(17):1292-9. PubMed ID: 9731736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study.
    Zeleniuch-Jacquotte A; Shore RE; Koenig KL; Akhmedkhanov A; Afanasyeva Y; Kato I; Kim MY; Rinaldi S; Kaaks R; Toniolo P
    Br J Cancer; 2004 Jan; 90(1):153-9. PubMed ID: 14710223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma.
    Xie SH; Ness-Jensen E; Langseth H; Gislefoss RE; Mattsson F; Lagergren J
    Int J Cancer; 2021 Feb; 148(4):905-913. PubMed ID: 32895915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.